DE69725745D1 - Injizierbare zusammensetzungen - Google Patents

Injizierbare zusammensetzungen

Info

Publication number
DE69725745D1
DE69725745D1 DE69725745T DE69725745T DE69725745D1 DE 69725745 D1 DE69725745 D1 DE 69725745D1 DE 69725745 T DE69725745 T DE 69725745T DE 69725745 T DE69725745 T DE 69725745T DE 69725745 D1 DE69725745 D1 DE 69725745D1
Authority
DE
Germany
Prior art keywords
warm
blooded animals
injectable compositions
diseases
moxidecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69725745T
Other languages
English (en)
Inventor
Colin Manson Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ashmont Holdings Ltd
Original Assignee
Ashmont Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26651622&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69725745(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NZ286752A external-priority patent/NZ286752A/en
Application filed by Ashmont Holdings Ltd filed Critical Ashmont Holdings Ltd
Application granted granted Critical
Publication of DE69725745D1 publication Critical patent/DE69725745D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69725745T 1996-06-05 1997-06-05 Injizierbare zusammensetzungen Expired - Lifetime DE69725745D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ286752A NZ286752A (en) 1996-06-05 1996-06-05 Stable injectable composition of endecticides
NZ29909396 1996-07-30
PCT/NZ1997/000073 WO1997046204A2 (en) 1996-06-05 1997-06-05 Injectable compositions

Publications (1)

Publication Number Publication Date
DE69725745D1 true DE69725745D1 (de) 2003-11-27

Family

ID=26651622

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69725745T Expired - Lifetime DE69725745D1 (de) 1996-06-05 1997-06-05 Injizierbare zusammensetzungen

Country Status (7)

Country Link
US (2) US6214367B1 (de)
EP (1) EP0928136B1 (de)
AT (1) ATE252316T1 (de)
AU (1) AU728221B2 (de)
CA (1) CA2259469A1 (de)
DE (1) DE69725745D1 (de)
WO (1) WO1997046204A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ280086A (en) * 1995-09-25 1997-08-22 Ashmont Holdings Ltd Injectable veterinary abamectin composition; also comprises a vegetable oil and an alcohol having 4 or more carbon atoms
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
US6524592B2 (en) 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
NO312056B1 (no) * 1998-06-09 2002-03-11 Alpharma As Aquatic Animal Hea Anvendelse av preparater til forebygging og behandling av parasitter hos fisk
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US20050009762A1 (en) * 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
KR100600406B1 (ko) * 2002-07-22 2006-07-14 주식회사 엘지생명과학 주사용 이버멕틴 조성물 및 그 제조방법
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
CN100459864C (zh) * 2006-05-19 2009-02-11 东北农业大学 多拉菌素、塞拉菌素水乳剂及其制备方法
AU2007266475B2 (en) 2006-05-30 2009-12-03 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
PT2157967E (pt) 2007-04-23 2013-04-03 Intarcia Therapeutics Inc Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
CN106310293A (zh) * 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
EP2296696B1 (de) 2008-06-05 2014-08-27 ImmunoVaccine Technologies Inc. Zusammensetzungen mit liposomen, einem antigen, einem polynucleotid und einem träger mit einer kontinuierlichen phase einer hydrophoben substanz
PL2396006T3 (pl) 2009-02-16 2013-06-28 Zoetis Llc Preparat zawierający doramektynę w dużej dawce
US8313752B2 (en) * 2009-04-14 2012-11-20 Merial Limited Macrocyclic lactone combination compositions, vaccines and methods for producing same
KR102148624B1 (ko) 2009-09-28 2020-08-26 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
WO2011043962A2 (en) * 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
NZ594610A (en) * 2011-08-16 2013-03-28 Virbac New Zealand Ltd Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
CN113876945A (zh) 2011-10-06 2022-01-04 免疫疫苗技术有限公司 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
US11077134B1 (en) 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11638714B2 (en) 2020-11-10 2023-05-02 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
CN114642632A (zh) * 2022-02-25 2022-06-21 河北科技大学 一种莫西克汀注射液及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143545A (en) 1965-03-25 1969-02-26 Wellcome Found Injectable vaccine emulsions
GB1171125A (en) 1966-06-08 1969-11-19 Glaxo Lab Ltd Improvements in or relating to Injectable Preparations
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4093629A (en) 1977-04-11 1978-06-06 Merck & Co., Inc. Derivatives of antibiotic substance milbemycin and processes therefor
NZ186851A (en) 1977-04-11 1984-12-14 Merck & Co Inc Glycosyloxy derivatives of milbemycin and parasiticidal compositions
SU627611A1 (ru) 1977-09-30 1980-02-05 В.П. Землякова Вакцинный препарат в.п. земл ковой против клостридиозов животных и птиц
PH15982A (en) 1977-10-03 1983-05-18 Merck & Co Inc Selective hydrogenation producta of c-076 compounds and derivatives thereof
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
NZ188459A (en) 1977-10-03 1982-09-07 Merck & Co Inc Derivatives of c-076 compounds and pesticidal compositions
IE48627B1 (en) * 1978-09-11 1985-04-03 Ici Tasman Ltd Injectable composition for the treatment,of helminthiasis and clostridial diseases in animals
ZA803063B (en) 1979-05-31 1981-05-27 Ici Australia Ltd Process
JPS57139012A (en) 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4606918A (en) 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4781920A (en) 1984-11-13 1988-11-01 American Cyanamid Company Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
US4784845A (en) 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
ES2052173T3 (es) * 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5639876A (en) * 1991-02-12 1997-06-17 Heska Corporation Nucleic acid molecules encoding novel parasitic helminth proteins
US5262400A (en) 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
NZ286586A (en) 1993-05-10 1997-10-24 Merck & Co Inc Avermectin formulation with polymer carrier, as a parasiticide
US5550153A (en) * 1994-11-14 1996-08-27 Kerz; Phillip D. Method for treating heartworm-infected canines
SI0750907T1 (en) * 1995-06-30 2002-08-31 American Cyanamid Company Stable macrolide and macrolide vaccine compositions

Also Published As

Publication number Publication date
WO1997046204A2 (en) 1997-12-11
AU2982997A (en) 1998-01-05
EP0928136A4 (de) 2001-11-14
AU728221B2 (en) 2001-01-04
US20010014336A1 (en) 2001-08-16
ATE252316T1 (de) 2003-11-15
US6214367B1 (en) 2001-04-10
EP0928136A2 (de) 1999-07-14
WO1997046204A3 (en) 1998-03-12
EP0928136B1 (de) 2003-10-22
CA2259469A1 (en) 1997-12-11
US6663879B2 (en) 2003-12-16

Similar Documents

Publication Publication Date Title
ATE252316T1 (de) Injizierbare zusammensetzungen
BRPI9809791B8 (pt) compostos imuno efetores de fosfato de aminoalquil glucosamina e composições compreendendo os mesmos
AR010375A1 (es) Composiciones endo-ectoparasiticidas
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DK0915898T3 (da) Krystalform I af clarithromycin
UY24268A1 (es) Composiciones estables de vacunas para la administración parenteral, método para su utilización
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
DK1121135T3 (da) Præparater af beta-glucaner og specifikke immunglobuliner
EP1314431A3 (de) Newcastle-Krankheitsvirus zur therapeutischen Verwendungen
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
IL73800A0 (en) Parasiticidal compositions containing ivermectin and their preparation
IL94167A (en) Immunoconjugate targeting 15A8 or ZME-018 antigens and comprising TNF or interleukin-1
EA200100224A1 (ru) Комбинированная терапия в-клеточных лимфом, предусматривающая введение антитела против cd20
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
BR9908391A (pt) Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina
BR0215392A (pt) Composições farmacêuticas compreendendo um inibidor de fosfodiesterase multifuncional e um inibidor de absorção de adenosina, bem como uso das mesmas
BR9604825A (pt) Citostáticos modificados por carboidratos
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
BR9900114A (pt) Composições de ciclodextrina.
EP1834670A3 (de) Avermectinen oder Milbemycine und bis-Aryl-Derivate enthaltende Anthelminthische Zusammensetzungen.
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
ES2182920T3 (es) Formulaciones solubles de 2-cloro02'-deoxiadenosina.

Legal Events

Date Code Title Description
8332 No legal effect for de